Latest Conference Coverage

In an interview with Pharma Commerce Associate Editor Don Tracy, Tiara Green, Interim CEO, Accessia Health offers insight on challenges faced by patient assistance organizations and how to face them.

In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC offers his thoughts on the Inflation Reduction Act and discusses current advocacy efforts.

Presentation offers insight on this aforementioned model that assists retail and specialty-lite brands.

In an interview with Pharma Commerce Associate Editor Don Tracy, Amy Niles, Chief Mission Officer, PAN Foundation offers her thoughts on the session and feedback from the audience at PAP 2024 in Philadelphia.

Fireside chat uncovers ways to leverage this technology in order to boost medication adherence, engagement, and outcomes.

In an interview with Pharma Commerce Associate Editor Don Tracy, Monique French, MPH, Senior Director, Patient Advocacy, Health Policy & Communications, Rx4Good provides insight on engaging multiple healthcare groups.

In an interview with Pharma Commerce Associate Editor Don Tracy, Michael Galarraga, LPC, ATR-BC, Pennsylvania State Representative, OutCare Health offers his thoughts on the breakout session and his experience in mental health counseling.

Panel discusses PAN Foundation’s inaugural “State of Patient Access” report, and dives deep into patient challenges.

In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC talks about his 'Health Equity Spotlight' panel and advocacy accomplishments.

Breakout session summarizes key areas that will affect all aspects of the industry.

Partner for Archbow Consulting discusses the conference, the IRA, and specifics of PAP business rules

Bill Trombetta, PhD, discusses successfully navigating what he calls “the coming perfect storm” in healthcare.

The conference hosts a diversity, equity, and inclusion (DE&I) Summit featuring personal insights and experiences.

Bayer executive talks Enable Holistic Hub and Provider Services panel.

Session discusses ways to integrate digital pharmacies and hubs.

Lexicon Pharmaceuticals exec discusses upcoming Enable Holistic Hub and Provider Services panel.

Panel uncovers ways to handle the increasing complexities and risks surrounding commercialization.

Conference keynote offers an industry outlook, including new commercialization challenges.

Blue Fin Group exec speaks on his upcoming feature.

Blue Fin Group executive highlights how leaders can plan for immediate profitable lifecycles and beyond.

SVP and Managing Director for Blue Fin Group offers a synopsis of the conference opener.

Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.

Conference presentation explores groundbreaking topics impacting the pharma industry.

Director of Berkeley Research Group explains changes to 340B moving forward.

Berkeley Research Group executive speaks about the role of manufacturers in 340B pricing.

Berkeley Research Group Director discusses what to expect at his upcoming session.

Session explores how on-market products have done, and what to expect from new biosimilars.

Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle.